By combining PD-1/CTLA-4 with the GVAX vaccine, both the CD8+/Treg ratios and IFN-γ+TNF-α+ CD8+ tumor-infiltrating lymphocytes increased significantly [206]. The gene discussed is CD8A; the disease is neoplasm.